Pharmaceutical

The Ceftizoxime Sodium (CAS 68401-82-1) market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Ceftizoxime Sodium (CAS 68401-82-1) is projected to grow from US$ xx m…

• SKU :

  SAC2052229
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Insomnia Pharmacological Treatment market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Insomnia Pharmacological Treatment is projected to grow from US$ xx mil…

• SKU :

  SAC2052224
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Thyroid Hormone Disorder Drug market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Thyroid Hormone Disorder Drug is projected to grow from US$ xx million in 20…

• SKU :

  SAC2052218
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Wound Dressings market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Wound Dressings is projected to grow from US$ xx million in 2021, and is projected to reac…

• SKU :

  SAC2052169
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Waldenstrom Macroglobulinemia Therapeutics market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Waldenstrom Macroglobulinemia Therapeutics is projected to grow…

• SKU :

  SAC2052166
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Veterinary Feed Supplement market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Veterinary Feed Supplement is projected to grow from US$ xx million in 2021, an…

• SKU :

  SAC2052163
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Vaccine Particulate Adjuvants market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Vaccine Particulate Adjuvants is projected to grow from US$ xx million in 20…

• SKU :

  SAC2052157
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The OTC Drug market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for OTC Drug is projected to grow from US$ xx million in 2021, and is projected to reach xx by 2030, …

• SKU :

  SAC2052138
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Tocopheryl Nicotinate market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Tocopheryl Nicotinate is projected to grow from US$ xx million in 2021, and is proje…

• SKU :

  SAC2052137
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Type 2 Diabetes Therapeutics market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Type 2 Diabetes Therapeutics is projected to grow from US$ xx million in 2021…

• SKU :

  SAC2052134
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Hydroxyurea market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Hydroxyurea is projected to grow from US$ xx million in 2021, and is projected to reach xx by …

• SKU :

  SAC2052120
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Agrobacterium Tumefaciens Competent Cells market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Agrobacterium Tumefaciens Competent Cells is projected to grow f…

• SKU :

  SAC2052118
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Interleukin 2 Receptor Subunit Alpha market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Interleukin 2 Receptor Subunit Alpha is projected to grow from US$ xx…

• SKU :

  SAC2052036
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Secondary Hyperparathyroidism Drug market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Secondary Hyperparathyroidism Drug is projected to grow from US$ xx mil…

• SKU :

  SAC2052017
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Paroxysmal Nocturnal Hemoglobinuria Treatment market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Paroxysmal Nocturnal Hemoglobinuria Treatment is projected t…

• SKU :

  SAC2052007
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0